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In previous work (1),  the authors have demonstrated that minute 
splenic autoplastic transplants  made 7  weeks prior  to  splenectomy 
protect a large percentage of splenectomized rats  against Bartonella 
muris anemia.  A  comparative histological study of the transplants 
of protected and unprotected rats revealed a regeneration of the pulp 
cells in the protected rats, and an exhaustion destruction of the pulp in 
the unprotected rats.  This supported the hypothesis that the reticu- 
lar and endothelial cells of the pulp of the spleen elaborate some inter- 
nal  secretory  substance  having  an  influence to  prevent  Bctrtonellc~ 
infection.  Lauda and Flaum (2) found that rats joined by parabiosis 
are protected against Bartonella muris anemia if the spleen of only one 
animal is removed.  From their experiments these investigators con- 
cluded that the protective action is due to a hormonal substance pro- 
duced in the spleen. 
Unsuccessful attempts have been made by numerous investigators to 
demonstrate some substance in the spleen which would replace this 
organ in protecting adult splenectomized rats against Bartonellc~ muris 
anemia.  During the past 3 years we have made many attempts to 
obtain  such an extract.  Feeding raw or cooked spleen of ox,  calf, 
pig, or rat had no effect on the course of the disease.  Recently, how- 
ever, lipoid extracts of the spleen have been prepared which possess 
the property of protecting splenectomized adult albino rats against 
Bartonella muris anemia in a large percentage of instances. 
Since the anemia is more severe in the male, only male rats were 
used in testing the extracts.  In no instance among 440 male rats of 
carrier stock used for studies of Bartonellct  muris anemia during the 
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past 3 years, has the anemia failed to develop following splenectomy. 
Similar observations on the prevalence of the disease in the male have 
been made by Ederle and Kriech (3).  It is plain that the spleen plays 
a specific r61e in the protective mechanism of the body to the infection. 
Rats of carrier stock are infected early in life, they recover, and remain 
carriers  of the infection.  1  Subsequent  splenectomy is followed by a 
recurrence of the infection with the development of a severe anemia. 
Preparation of the Extract 
The method of extraction  is the same as that  used by tIartman  (10) in the 
preparation  of the cortical  suprarenal  hormone.  Ox spleens were obtained from 
freshly killed animals,  packed  in ice, and immediately  transported to  the  labor- 
atory.  10 pounds of spleen were extracted at a time. 
The fat and as much of the capsule as possible is stripped  off, and the pulp is 
ground in a meat grinder.  The trimming and grinding is done by artificial light 
and the material kept cold.  The ground material is placed in large round bottom 
flasks  and  1.5 liters of peroxide-free ether is added for each kilo of spleen.  The 
ether extraction is done in the dark in an atmosphere of COs, and the extraction  is 
assisted by a rotary motion of 15 to 20 rotations per minute.  More rapid agitation 
may result  in emulsification.  If possible the temperature of the room should be 
kept below 10-12"C.  The flasks are shaken for a period of 3 hours, and allowed to 
stand  overnight.  The  ether  is  decanted,  and  rapidly  filtered  through  coarse 
filter paper.  The ether extraction  is repeated  for a total of 3 extractions.  The 
ether removed is evaporated at a temperature of 15°C. in vacuo.  All the ether 
fractions are added together.  It is best to evaporate the ether immediately  after 
decanting  and to add the new fractions  to the residue.  The residue of the ether 
extraction is now extracted with 95 per cent alcohol.  100 cc. of 95 per cent alcohol 
is used for each kilo of spleen extracted.  The alcohol is warmed  to 60°C. for a 
period of 30 minutes,  the flask being shaken every 10 or 15 minutes.  The flask is 
slowly cooled to ice temperature  and the alcohol extract decanted.  The same 
quantity of alcohol is again  added,  and extraction  repeated  4 times,  to insure 
thorough extraction. 
The alcohol fractions are pooled, and chilled to  -10°C. for 2 hours in chopped 
ice to which CaC12 has been added.  This process causes the precipitation  of large 
amounts of cerebrosides.  The chilled material is then rapidly filtered in the ice 
box, and the filtrate  is now a clear brownish yellow liquid.  It is essential  that 
filtration be done rapidly and in the cold.  If the filtrate  is not clear the chilling 
process should be repeated before proceeding.  The spleen contains large amounts 
of inert lipoids and their removal is attended with difficulty.  The alcohol filtrate 
1 See previous publications  of the authors on this subject  (4-8).  For a review 
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is now evaporated to one-third its volume in vacuo at a  temperature of 45-50°C. 
The alcohol fractions will keep for several weeks.  The reduced volume of alcohol 
is again chilled, and filtered in the manner outlined above.  The filtrate is now 
evaporated to dryness in vacuo at 45-50°C.  The residue is repeatedly extracted 
with a small amount of ether.  More complete extraction is obtained by agitation 
and scraping with a  rubber "policeman" during the process.  This procedure is 
repeated 4 times with at least 10 ec. of ether and is carried out in the dark room by 
red light, the flask being kept on ice during the procedure.  The ether extractions 
are filtered through coarse and then fine filter paper, and evaporated to dryness 
in vacuo at a low temperature.  Great difficulty  will be encountered in this last step 
if there is a  large amount of alcohol residue.  In that case, in order to eliminate 
inert material, it is advisable to do another alcohol extraction with subsequent 
chilling and filtering. 
The final residue of the last ether extraction is a small amount of brownish oily 
material.  If the extractions have been carefully carried out not more than a few 
drops of  this  material  remain.  It is thoroughly emulsified with distilled water 
(50 cc. for 5000  gin.) in the required amount, and filtered through a  Seitz filter. 
The resultant aqueous  extract has a  yellowish tinge.  It is brought  up  to  iso- 
tonicity, and preserved with 0.1 per cent of benzoic acid.  Physiological salt solu- 
tion may be used for the emulsification in place of distilled water.  1 cc. of the 
extract is equivalent to  100 gm.  of spleen.  The aqueous extract will keep for 
several weeks if a preservative is added. 
Numerous attempts to obtain larger yields were made by suspending the oily 
residue of the final ether extraction in olive oil.  The resultant emulsion produced 
severe peritoneal irritation when injected intraperitoneally into rats.  An attempt 
to fractionate the final ether-soluble material into acetone-soluble and insoluble 
fractions was made in the following manner:  An excess of acetone was added to the 
final ether extract until no further precipitation occurred.  The precipitate was 
filtered off and dissolved in benzine.  The filtrate was evaporated and dried in 
vacuo, taken up in water, and passed through a  Seitz filter.  The benzine extract 
of the acetone-insoluble fraction was evaporated to dryness in vacuo and taken up 
in water.  When tested neither the acetone-soluble nor the acetone-insoluble frac- 
tion showed evidence of potency. 
Extracts of fresh spleen, made by extraction either with acetone or with HCI, 
proved unsuccessful. 
On analysis, the final aqueous lipoid extract gave no reactions for either protein 
or carbohydrate.  Traces of nitrogen were detectable (Kjeldahl).  No  copper or 
iron could be detected by qualitative tests. 
EX_PERIMENTAL  DATA 
Twenty-nine splenectomized male albino rats of carrier stock were tested with 
the lipoid extract of spleen.  Of these, 8 were 6 to 8 weeks of age and 21 were 3 to 
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amounts of 0.5  cc.  The  injections were started 24  hours prior to splenectomy. 
Hemoglobin estimations with the Dare hemoglobinometer, red blood cell counts, 
and smears were made daily.  A  rat was considered completely protected if the 
blood count and hemoglobin did not show greater variation than is observed in 
normal rats, and Bartonella bodies were not found on the red cells.  The animals 
were under observation for at least 1 month following splenectomy, to eliminate the 
possibility  of a delayed appearance of the anemia3  All the rats were of Bartonella 
muris carrier stock, raised in the laboratory, and used for studies of this anemia 
during a period of several years. 
TABLE  I 
The Protective Action of an Aqueous Lipoid Extract* of Spleen  against  Bartonella 
murls Anemia in Male Splenectomized Rats of Carrier Stock 
No. of rats  Age  Completely  protectedt  Unprotected  Protected 
Treated 
8 
21 
Controls 
0.5  cc. saline twice 
daily 
40 
Theelin 
(ovarian  follicular 
hormone)  10  units 
per day 
12 
6-8 wks. 
3-5 mos. 
3-5 mos. 
3-5 mos. 
3 
14 
40 
12 
~er cent 
37 
66 
* The  extract  was  administered twice  daily intraperitoneally in  amounts  of 
0.5 cc. (1 cc. of the extract is equivalent to 100 gin. of spleen). 
t  A rat was considered completely protected if the blood count and hemoglobin 
did not show greater daily variations than is found in normal rats, and if Bar- 
tondla bodies were not found in the red cells. 
In  the  first  group  of  immature  rats,  complete  protection  against 
Bartonella muris infection and anemia was obtained in 3  out of 8  rats. 
In the second group of mature  rats,  14 out of 21  rats were completely 
protected.  Of 40 male splenectomized rats injected daily with physi- 
ological salt  solution,  all  developed Bartonella  muris  anemia.  As  a 
In  the control splenectomized untreated rats  the anemia develops in  most 
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further control, the ovarian follicular hormone, Theelin (Parke, Davis 
and Co.) an aqueous extract of the crystalline hormone, was adminis- 
tered to 12 adult male splenectomized rats in amounts of 10 rat units 
per day injected intraperitoneally.  No protection against Bartonella 
muris anemia was observed. 
Rats of carrier stock between the ages of 6 and 8 weeks, with the 
spleen intact, suffer from a  severe infection of Bartonella  muris with 
little or no anemia.  This is manifested by the occasional appearance 
of Bartonella  muris bodies on the blood cells and the marked hyper- 
plasia  and  congestion  of  the  spleen.  Protection  in  such  animals 
against anemia following splenectomy by an extract of the spleen is, 
therefore, less effective.  In the adult, the infection is latent and the 
spleen shows little evidence of hyperplasia and congestion.  In these 
rats protection was obtained in a large percentage of instances. 
DISCUSSION 
Numerous investigators have found that liver extracts potent in the 
treatment of pernicious anemia have no effect on the course of Barton- 
ella muris anemia,  Recently EderIe and Kriech (3) have studied the 
effects of injections of a commercial extract of liver, administered sub- 
cutaneously in amounts equivalent to 2 gm. of liver a day.  They ob- 
served that the anemia in the treated rats was less severe, and the mor- 
tality was less than in the control group.  On the other hand, Vedder 
(11) obtained entirely negative results with liver therapy. 
The literature  contains numerous references to  the use of spleen 
extracts in various diseases, but interpretation of such results is difficult. 
There are many evidences of splenic function, but their significance is 
not  plain.  The  body of most  animals  contains  accessory splenoid 
tissue in varying amounts.  The rat possesses less hemolymph tissue 
than other mammals (12) and a much larger spleen, and the removal of 
the spleen in this animal seems to have  an  unusually marked effect 
on resistance.  The specific relation between Barlonella  muris anemia 
in the rat and the function of the spleen offers a possible index of func- 
tion of the pulp tissue of this organ. 
The protective action of a  splenic extract against Bartonella  muris 
anemia in the splenectomized adult male rat upholds the hypothesis 
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SUM.MARY 
An  aqueous  lipoid  extract  of  ox  spleen  was  prepared  which  pro- 
tects adult  male albino  rats  of carrier  stock in  a  large  percentage  of 
instances  against  BartoneUa muris anemia  folloMng splenectomy.  It 
is suggested that the extract contains a  specific hormonal  substance. 
We wish to thank Dr. David Marine for his suggestions and criticism 
throughout tbe course of this work. 
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